Supercharge Your Innovation With Domain-Expert AI Agents!

Application of MLN4924 in preparation of choroidal neovascularization treatment medicines

A technology for new blood vessels and therapeutic drugs, applied in the field of medicine, can solve the problems of non-response, repeated intraocular injection of anti-VEGF drugs, etc., and achieve the effect of reducing exudation and excellent effect

Active Publication Date: 2020-09-15
NANTONG UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to provide an ubiquitin-like modification inhibitor-MLN4924 in the treatment of choroidal neovascularization, so as to solve the problem of repeated intraocular injection and non-response of anti-VEGF drugs in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of MLN4924 in preparation of choroidal neovascularization treatment medicines
  • Application of MLN4924 in preparation of choroidal neovascularization treatment medicines
  • Application of MLN4924 in preparation of choroidal neovascularization treatment medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0027] (1) Establishment of mouse CNV model

[0028] Krypton laser induced CNV mice, anesthetized by intraperitoneal injection of 0.5% pentobarbital, compound tropicamide for mydriasis, and irradiated with hand-held light to keep the mouse body temperature. The mouse experimental eye was fixed in front of the slit lamp, with the aid of 1% methylcellulose, a 5.4mm hand-held contact lens was placed in front of the cornea, and a krypton ion laser was used, with a laser wavelength of 647.1nm, a power of 300mw, and a spot diameter. 50 μm, exposure time 0.05 seconds. Around the optic disc and equidistant photocoagulation at 2 nipple diameters away from the optic disc, a total of 4 points, located at 3, 6, 9, and 12 points, respectively, when bubbles are seen, it indicates that Bruch's membrane has been broken, and no vitreous hemorrhage is light. Set success criteria.

[0029] (2) Intraperitoneal injection of mice

[0030]Mice in CNV group were randomly divided into five groups: ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines, and in particular relates to an application of MLN4924 in preparation of choroidal neovascularization treatment medicines. The application has the advantages that the application of the MLN4924 in choroidal neovascularization treatment is provided, and the problems of repeated intraocular injection of anti-VEGF drugs and no response to part of patients in the prior art are solved. The MLN4924 is used in an intraperitoneal injection administration mode, so that intraocular repeated injection and possible side effects such as intraocularinflammation are avoided. Animal experiments prove that the effect of MLN4924 in reducing the exudation, area and volume of CNV is superior to that of an anti-VEGF drug ranibizumab which is clinically used at present.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the application of a kind of ubiquitin-like modification inhibitor-MLN4924 in the preparation of choroidal neovascularization therapeutic drugs. Background technique [0002] Age-related macular degeneration (AMD) is a progressive and degenerative eye disease that occurs in people over the age of 50. According to pathological changes, AMD is divided into two categories: dry and wet. Dry AMD is characterized by atrophy of the retinal pigment epithelium and the photoreceptor cells on it, while wet AMD mainly leads to pathological choroidal neovascularization (CNV), which is characterized by abnormal blood vessel growth in the central area of ​​the retina, that is, the submacula. Characteristically, these abnormal blood vessels break through Bruch's membrane and penetrate deep into the subretinal area of ​​the pigment epithelium, resulting in exudation, hemorrhage, retinal edema, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/519A61P9/00
CPCA61K31/519A61P9/00
Inventor 刘晓娟朱曼辉孙晓雷李爱红郭爱松
Owner NANTONG UNIVERSITY
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com